Nanopath has developed deep technological breakthroughs that have the potential to change the molecular diagnostic paradigm. They are commercializing a first-in-class molecular diagnostic platform to enable scalable, point-of-care disease diagnosis.

Nanopath has developed deep technological breakthroughs that have the potential to change the molecular diagnostic paradigm. They are commercializing a first-in-class molecular diagnostic platform to enable scalable, point-of-care disease diagnosis.